Concepedia

Author

José Vicente

United States Food and Drug AdministrationORCID

Also Known As

J Vicente, J. Vicente, Jose Vicente, José A. Linares Vicente, José Vicente, Vicente, José

82

Publications

2.6K

Citations

22

H-Index

85

Concepts

All Affiliations

United States Food and Drug AdministrationCenter for Drug Evaluation and ResearchUniversidad de ZaragozaCenter for Devices and Radiological HealthOffice of Science
JV

About

José Vicente is an author at United States Food and Drug Administration specializing in cardiology, medicine, and electrophysiology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

14

15

1.2K

2

Engineering

8

8

425

3

Public Health

7

7

506

4

Health Sciences

2

2

88

5

Social Sciences

1

1

41

José Vicente

×

38

Publications

2.4K

Citations

21

H-Index

YearCitations

An evaluation of 30 clinical drugs against the comprehensive in vitro proarrhythmia assay (CiPA) proposed ion channel panel

William Crumb, José Vicente, Lars Johannesen,

Journal of Pharmacological and Toxicological Methods

2016

286

Drowsiness detection using heart rate variability

José Vicente, Pablo Laguna, Ariadna Bartra,

Medical & Biological Engineering & Computing

2016

273

Comprehensive Translational Assessment of Human-Induced Pluripotent Stem Cell Derived Cardiomyocytes for Evaluating Drug-Induced Arrhythmias

Ksenia Blinova, Jayna Stohlman, José Vicente,

Toxicological Sciences

2016

271

Differentiating Drug-Induced Multichannel Block on the Electrocardiogram: Randomized Study of Dofetilide, Quinidine, Ranolazine, and Verapamil

Lars Johannesen, José Vicente, Jay W. Mason,

Clinical Pharmacology & Therapeutics

2014

257

Late sodium current block for drug‐induced long QT syndrome: Results from a prospective clinical trial

Lars Johannesen, José Vicente, Mason Jw,

Clinical Pharmacology & Therapeutics

2015

142

Comprehensive T wave Morphology Assessment in a Randomized Clinical Study of Dofetilide, Quinidine, Ranolazine, and Verapamil

José Vicente, Lars Johannesen, Jay W. Mason,

Journal of the American Heart Association

2015

126

Common Genetic Variant Risk Score Is Associated With Drug-Induced QT Prolongation and Torsade de Pointes Risk

David G. Strauss, José Vicente, Lars Johannesen,

Circulation

2017

123

Comprehensive In Vitro Proarrhythmia Assay (CiPA) Update from a Cardiac Safety Research Consortium / Health and Environmental Sciences Institute / FDA Meeting

David G. Strauss, Gary A. Gintant, Zhihua Li,

Therapeutic Innovation & Regulatory Science

2018

107

Assessment of Multi‐Ion Channel Block in a Phase I Randomized Study Design: Results of the Ci<scp>PA</scp> Phase I <scp>ECG</scp> Biomarker Validation Study

José Vicente, Robbert Zusterzeel, Lars Johannesen,

Clinical Pharmacology & Therapeutics

2018

91

Improving the Assessment of Heart Toxicity for All New Drugs Through Translational Regulatory Science

Lars Johannesen, José Vicente, Richard A. Gray,

Clinical Pharmacology & Therapeutics

2013

86

Page 1